Akt Activates the Mammalian Target of Rapamycin by Regulating Cellular ATP Level and AMPK Activity
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
The serine/threonine kinase Akt is an upstream positive regulator of the mammalian target of rapamycin (mTOR). However, the mechanism by which Akt activates mTOR is not fully understood. The known pathway by which Akt activates mTOR is via direct phosphorylation and inhibition of tuberous sclerosis complex 2 (TSC2), which is a negative regulator of mTOR. Here we establish an additional pathway by which Akt inhibits TSC2 and activates mTOR. We provide for the first time genetic evidence that Akt regulates intracellular ATP level and demonstrate that Akt is a negative regulator of the AMP-activated protein kinase (AMPK), which is an activator of TSC2. We show that in Akt1/Akt2 DKO cells AMP/ATP ratio is markedly elevated with concomitant increase in AMPK activity, whereas in cells expressing activated Akt there is a dramatic decrease in AMP/ATP ratio and a decline in AMPK activity. Currently, the Akt-mediated phosphorylation of TSC2 and the inhibition of AMPK-mediated phosphorylation of TSC2 are viewed as two separate pathways, which activate mTOR. Our results demonstrate that Akt lies upstream of these two pathways and induces full inhibition of TSC2 and activation of mTOR both through direct phosphorylation and by inhibition of AMPK-mediated phosphorylation of TSC2. We propose that the activation of mTOR by Akt-mediated cellular energy and inhibition of AMPK is the predominant pathway by which Akt activates mTOR in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AKT positively regulates mTOR (activator of PGC-1α) by direct inhibition of the inhibitory complex TSC1/2 and by inhibition of the mTOR inhibitors AMPK (activator of PGC-1α) and GSK3b (regulator of PGC-1α turnover) [67, 70].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
Self-citationTSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,656
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
THE AMP-ACTIVATED/SNF1 PROTEIN KINASE SUBFAMILY: Metabolic Sensors of the Eukaryotic Cell?
Hardie, D. G., Carling, D., & Carlson, M. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.821 · Cited by 1,435
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Hawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D., & Hardie, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27879 · Cited by 1,264
Research works printed but not linked: 3
- Sapkota, 2002, Biochem. J., 362, 481, 10.1042/bj3620481 · doi:10.1042/bj3620481
- Sekulic, 2000, Cancer Res., 60, 3504
- Parsons, 2003, Methods Mol. Biol., 222, 147
Cited by
Items 101–200 of 553
Sirt2 Deacetylase Is a Novel AKT Binding Partner Critical for AKT Activation by Insulin
Ramakrishnan, G., Davaakhuu, G., Kaplun, L., Chung, W.-C., Rana, A., Atfi, A., Miele, L., & Tzivion, G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537266 · Cited by 125
Krawiec, B. J., Nystrom, G. J., Frost, R. A., Jefferson, L. S., & Lang, C. H. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00622.2006 · Cited by 123
Dunn, E. F., & Connor, J. H. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-396456-4.00002-x · Cited by 135
The Pim protein kinases regulate energy metabolism and cell growth
Beharry, Z., Mahajan, S., Zemskova, M., Lin, Y.-W., Tholanikunnel, B. G., Xia, Z., Smith, C. D., & Kraft, A. S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013214108 · Cited by 124
Ren, J., Yang, L., Zhu, L., Xu, X., Ceylan, A. F., Guo, W., Yang, J., & Zhang, Y. (2017) · Aging Cell · doi:10.1111/acel.12616 · Cited by 123
Gratia, S., Kay, L., Potenza, L., Seffouh, A., Novel-Chaté, V., Schnebelen, C., Sestili, P., Schlattner, U., & Tokarska-Schlattner, M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs134 · Cited by 120
Varela‐López, A., Battino, M. A., Navarro‐Hortal, M. D., Giampieri, F., Forbes-Hernández, T. Y., Romero‐Márquez, J. M., Collado, R., & Quiles, J. L. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110834 · Cited by 133
Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention
Tong, X., & Pelling, J. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113139990119 · Cited by 109
Zhang, X., Song, Y., Feng, M., Zhou, X., Lu, Y., Gao, L., Yu, C., Jiang, X., & Zhao, J. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m047654 · Cited by 107
Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity
Thellung, S., Corsaro, A., Nizzari, M., Barbieri, F., & Florio, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040901 · Cited by 118
Chopra, I., Li, H. F., Wang, H., & Webster, K. A. (2012) · Diabetologia · doi:10.1007/s00125-011-2407-y · Cited by 116
“Quantification confirmed significant AMPK-dependent, compound-C-sensitive incorporation of [32P]ATP into the IR (Fig.”
InfluentialLi, D., Wang, D., Wang, Y., Ling, W., Feng, X., & Xia, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.159772 · Cited by 115
Magnoni, L. J., Vraskou, Y., Palstra, A. P., & Planas, J. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031219 · Cited by 109
Ning, J., Xi, G., & Clemmons, D. R. (2011) · Endocrinology · doi:10.1210/en.2011-0155 · Cited by 112
Liao, X., Majithia, A. R., Huang, X., & Kimmel, A. R. (2008) · Amino Acids · doi:10.1007/s00726-008-0100-3 · Cited by 118
The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin
Stylianou, K., Petrakis, I., Mavroeidi, V., Stratakis, S., Vardaki, E. A., Perakis, K., Stratigis, S., Passam, A. M., Papadogiorgaki, E., Giannakakis, K., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq496 · Cited by 119
Kaur, S., Lal, L., Sassano, A., Majchrzak-Kita, B., Srikanth, M., Baker, D. P., Petroulakis, E., Hay, N., Sonenberg, N., Fish, E. N., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607365200 · Cited by 111
Self-citationInteraction between the AMP-Activated Protein Kinase and mTOR Signaling Pathways
KIMBALL, S. R. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000233796.16411.13 · Cited by 109
Autophagic pathways as new targets for cancer drug development
Liu, B., Cheng, Y., Liu, Q., Bao, J.-K., & Yang, J.-M. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.118 · Cited by 110
Biology of Chronic Lymphocytic Leukemia in Different Microenvironments
Herishanu, Y., Katz, B., Lipsky, A. H., & Wiestner, A. U. (2013) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.01.002 · Cited by 118
mTOR at the crossroads of T cell proliferation and tolerance
Mondino, A., & Mueller, D. L. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.02.008 · Cited by 108
Yentrapalli, R., Azimzadeh, O., Sriharshan, A., Malinowsky, K., Merl, J., Wojcik, A., Harms-Ringdahl, M., Atkinson, M. J., Becker, K.-F., Haghdoost, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070024 · Cited by 103
TSC1/TSC2 signaling in the CNS
Han, J. M., & Sahin, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.02.001 · Cited by 105
“In addition, AMP-activated protein kinase (AMPK) can phosphorylate TSC2 on a different set of residues than Akt and ERK and potentially increase the ability of TSC1/2 to inhibit the mTORC1 activity, thereby protecting cells from excessive energy use during low energy states [26,27].”
BackgroundCurrent Perspectives on Akt Akt-ivation and Akt-ions
Matheny, R. W., & Adamo, M. L. (2009) · Experimental Biology and Medicine · doi:10.3181/0904-mr-138 · Cited by 125
The FoxO–BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress
Lin, A., Yao, J., Zhuang, L., Wang, D., Han, J., Lam, E. W.-F., TCGA Research Network, & Gan, B. (2014) · Oncogene · doi:10.1038/onc.2013.273 · Cited by 103
Antagonistic control of muscle cell size by AMPK and mTORC1
Mounier, R., Lantier, L., Leclerc, J., Sotiropoulos, A., Foretz, M., & Viollet, B. (2011) · Cell Cycle · doi:10.4161/cc.10.16.17102 · Cited by 100
Akt isoforms and glucose homeostasis – the leptin connection
Hay, N. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.09.003 · Cited by 101
Self-citationRole of AMP-Activated Protein Kinase in the Molecular Adaptation to Endurance Exercise
WINDER, W. W., TAYLOR, E. B., & THOMSON, D. M. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000233798.62153.50 · Cited by 102
Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment
Inoki, K., & Guan, K.-L. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp032 · Cited by 98
Williamson, D. L., Bolster, D. R., Kimball, S. R., & Jefferson, L. S. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00566.2005 · Cited by 96
Roccaro, A. M., Sacco, A., Husu, E. N., Pitsillides, C. M., Vesole, S., Azab, A. K., Azab, F., Melhem, M. R., Ngo, H. T., Quang, P., et al. (2009) · Blood · doi:10.1182/blood-2009-07-235747 · Cited by 103
Karnevi, E., Said, K., Andersson, R., & Rosendahl, A. H. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-235 · Cited by 99
LKB1/AMPK/mTOR Signaling Pathway in Non-small-cell Lung Cancer
Han, D., Li, S.-J., Zhu, Y.-T., Liu, L., & Li, M.-X. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.7.4033 · Cited by 95
Shiau, J., Chuang, Y.-T., Tang, J., Yang, K., Chang, F., Hou, M., Yen, C., & Chang, H. (2022) · Antioxidants · doi:10.3390/antiox11091845 · Cited by 106
Li, H., Ge, Y., Zheng, X., & Zhang, L. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.04.036 · Cited by 98
Williamson, D. L., Kubica, N., Kimball, S. R., & Jefferson, L. S. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103481 · Cited by 96
Defining a metabolic landscape of tumours: genome meets metabolism
Nanda, C. S., Venkateswaran, S. V., Patani, N., & Yuneva, M. O. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0663-7 · Cited by 106
Role of the PI3K/Akt signaling pathway in liver ischemia reperfusion injury: a narrative review
Wang, M., Zhang, J., & Gong, N. (2022) · Annals of Palliative Medicine · doi:10.21037/apm-21-3286 · Cited by 94
YAN, C.-M., Chai, E., Cai, H., MIAO, G.-Y., & Ma, W. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3266 · Cited by 101
Kuznetsoff, J. N., Leclerc, G. J., Leclerc, G. M., & Barredo, J. C. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0777 · Cited by 99
Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Gaykalova, D. A., Mambo, E., Choudhary, A. K., Houghton, J., Buddavarapu, K., Sanford, T., Darden, W., Adai, A. T., Hadd, A. G., Latham, G. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093102 · Cited by 99
MUC1: A novel metabolic master regulator
Mehla, K., & Singh, P. K. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.01.001 · Cited by 106
The mTOR Signaling Pathway in the Brain: Focus on Epilepsy and Epileptogenesis
Russo, E., Citraro, R., Constanti, A., & Sarro, G. D. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8314-5 · Cited by 98
Neuroprotective effects of curcumin through autophagy modulation
Forouzanfar, F., Read, M. I., Barreto, G. E., & Sahebkar, A. (2019) · IUBMB Life · doi:10.1002/iub.2209 · Cited by 96
Kim, N., Jeong, S., Jing, K., Shin, S., Kim, S., Heo, J. Y., Kweon, G., Park, S., Wu, T., Park, J., et al. (2015) · BioMed Research International · doi:10.1155/2015/239764 · Cited by 271
Roles of AKT1 and AKT2 in non‐small cell lung cancer cell survival, growth, and migration
Lee, M. W., Kim, D. S., Lee, J. H., Lee, B. S., Lee, S. H., Jung, H. L., Sung, K. W., Kim, H. T., Yoo, K. H., & Koo, H. H. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02025.x · Cited by 89
Jin, Q., Feng, L., Behrens, C., Bekele, B. N., Wistuba, I. I., Hong, W.-K., & Lee, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2401 · Cited by 87
Regulation of the PI3K pathway through a p85α monomer–homodimer equilibrium
Cheung, L. W. T., Walkiewicz, K. W., Besong, T. M. D., Guo, H., Hawke, D. H., Arold, S. T., & Mills, G. B. (2015) · eLife · doi:10.7554/elife.06866 · Cited by 85
Mitochondrial dynamics: orchestrating the journey to advanced age
Biala, A. K., Dhingra, R., & Kirshenbaum, L. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.04.015 · Cited by 82
“This activates AMP-activated protein kinase (AMPK), a central regulator ofmetabolic signalingwhich induces growth arrest and autophagy by inhibiting mechanistic target of rapamycin (mTOR) pathway [69,70].”
BackgroundBurke, J. D., Platanias, L. C., & Fish, E. N. (2014) · Journal of Virology · doi:10.1128/jvi.02649-13 · Cited by 86
Yuan, D., Zhou, S., Liu, S., Li, K., Zhao, H., Long, S., Liu, H., Xie, Y., Su, Y., Yu, F., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000963117 · Cited by 96
Chapter 2 Cell Signaling in Protein Synthesis
Mahoney, S. J., Dempsey, J. M., & Blenis, J. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)90002-3 · Cited by 92
Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies
Bilanges, B., & Stokoe, D. (2007) · Oncogene · doi:10.1038/sj.onc.1210431 · Cited by 95
Saha, S., Sadhukhan, P., Sinha, K., Agarwal, N., & Sil, P. C. (2016) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2016.01.011 · Cited by 79
Emerging Roles for AKT Isoform Preference in Cancer Progression Pathways
Degan, S. E., & Gelman, I. H. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-1066 · Cited by 89
Ma, T., Tzavaras, N., Tsokas, P., Landau, E. M., & Blitzer, R. D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4761-11.2011 · Cited by 77
Thomas, S., Arun, K. B., Syama, H. P., Reshmitha, T. R., & Nisha, P. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00640 · Cited by 82
Reyes, R., Wani, N. A., Ghoshal, K., Jacob, S. T., & Motiwala, T. (2016) · Gene Expression · doi:10.3727/105221616x693855 · Cited by 78
Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stress
Cheng, K. W., Agarwal, R., Mitra, S., Lee, J., Carey, M. S., Gray, J. W., & Mills, G. B. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100193 · Cited by 83
Energy Homeostasis and Cancer Prevention: The AMP-Activated Protein Kinase
Fay, J. R., Steele, V., & Crowell, J. A. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0166 · Cited by 78
Mitochondrial Dynamics and Motility Inside Living Vascular Endothelial Cells: Role of Bioenergetics
Giedt, R. J., Pfeiffer, D. R., Anastasios Matzavinos, A., Kao, C., & Alevriadou, B. R. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-012-0568-6 · Cited by 82
Meyer, P., Maity, P., Burkovski, A., Schwab, J., Müssel, C., Singh, K., Ferreira, F. F., Krug, L., Maier, H. J., Wlaschek, M., et al. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005741 · Cited by 75
Longevity Factor FOXO3: A Key Regulator in Aging-Related Vascular Diseases
Zhao, Y., & Liu, Y. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.778674 · Cited by 83
Lo, A. K., Lo, K. W., Ko, C., Young, L. S., & Dawson, W. O. (2013) · The Journal of Pathology · doi:10.1002/path.4201 · Cited by 74
Santi, S. A., & Lee, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014614 · Cited by 77
TBK1 (TANK-binding kinase 1)-mediated regulation of autophagy in health and disease
Herhaus, L. (2021) · Matrix Biology · doi:10.1016/j.matbio.2021.01.004 · Cited by 76
Fornari, F., Giovannini, C., Piscaglia, F., & Gramantieri, L. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s285726 · Cited by 75
The dark face of AMPK as an essential tumor promoter
Jeon, S., & Hay, N. (2012) · Cellular Logistics · doi:10.4161/cl.22651 · Cited by 75
Self-citationMultiple Roles of SIRT2 in Regulating Physiological and Pathological Signal Transduction
Zhu, C., Dong, X., Wang, X., Zheng, Y., Qiu, J., Peng, Y., Xu, J., Chai, Z., & Liu, C. (2022) · Genetics Research · doi:10.1155/2022/9282484 · Cited by 77
Dixit, M., Bess, E., Fisslthaler, B., Hartel, F. V., Noll, T., Busse, R., & Fleming, I. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm017 · Cited by 70
Neitzel, C., Demuth, P., Wittmann, S., & Fahrer, J. (2020) · Cancers · doi:10.3390/cancers12071731 · Cited by 76
Koyanagi, M., Asahara, S.-I., Matsuda, T., Hashimoto, N., Shigeyama, Y., Shibutani, Y., Kanno, A., Fuchita, M., Mikami, T., Hosooka, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023238 · Cited by 69
Bilanges, B., Argonza-Barrett, R., Kolesnichenko, M., Skinner, C., Nair, M., Chen, M., & Stokoe, D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02136-06 · Cited by 68
AMP-activated kinase (AMPK)-generated signals in malignant melanoma cell growth and survival
Woodard, J., & Platanias, L. C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.052 · Cited by 57
T-cell immunometabolism against cancer
Jiang, S., & Yan, W. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.09.003 · Cited by 70
DeSalvo, J., Kuznetsoff, J. N., Du, J., Leclerc, G. M., Leclerc, G. J., Lampidis, T. J., & Barredo, J. C. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0125 · Cited by 71
Metabolic regulation of organelle homeostasis in lupus T cells
Caza, T. N., Talabér, G., & Perl, A. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.07.001 · Cited by 66
The Phosphatidylinositol 3-Kinase/Akt Cassette Regulates Purine Nucleotide Synthesis
Wang, W., Fridman, A., Blackledge, W., Connelly, S., Wilson, I. A., Pilz, R. B., & Boss, G. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806707200 · Cited by 72
Core erythropoietin receptor signals for late erythroblast development
Menon, M. P., Fang, J., & Wojchowski, D. M. (2005) · Blood · doi:10.1182/blood-2005-02-0684 · Cited by 67
mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review
Statz, C. M., Patterson, S. E., & Mockus, S. M. (2016) · Targeted Oncology · doi:10.1007/s11523-016-0453-6 · Cited by 71
Peyot, M.-L., Gray, J. P., Lamontagne, J., Smith, P. J. S., Holz, G. G., Madiraju, S. R. M., Prentki, M., & Heart, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006221 · Cited by 64
Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer’s Disease
Wang, X., Zimmermann, H. R., & Ma, T. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-181043 · Cited by 69
Talaei, F., van Praag, V. M., & Henning, R. H. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.04.011 · Cited by 65
The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival
William, W. N., Kim, J.-S., Liu, D. D., Solis, L. M., Behrens, C., Lee, J. J., Lippman, S. M., Kim, S., Hong, W. K., Wistuba, I. I., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr036 · Cited by 63
Responses of energy homeostasis and lipid metabolism in Penaeus vannamei exposed to ammonia stress
Wang, T., Li, W., Shan, H., & Ma, S. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.737092 · Cited by 64
Manne, N. D. P. K., Lima, M., Enos, R. T., Wehner, P. S., Carson, J. A., & Blough, E. R. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1893 · Cited by 66
KSHV-Mediated Angiogenesis in Tumor Progression
Purushothaman, P., Uppal, T., Sarkar, R., & Verma, S. C. (2016) · Viruses · doi:10.3390/v8070198 · Cited by 70
Xu, P., Yin, K., Tang, X., Tian, J., Zhang, Y., Ma, J., Xu, H., Xu, Q., & Wang, S. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109458 · Cited by 61
Cam, M., Bid, H. K., Xiao, L., Zambetti, G. P., Houghton, P. J., & Cam, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.530303 · Cited by 58
Vallianou, N. G., Evangelopoulos, A. A., & Kazazis, C. E. (2013) · The Review of Diabetic Studies · doi:10.1900/rds.2013.10.228 · Cited by 72
Tong, X., Smith, K. A., & Pelling, J. C. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20793 · Cited by 62
Lee, W., Lin, R.-J., Lin, S.-Y., Chen, Y.-C., Lin, H.-M., & Liang, Y. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2036559 · Cited by 60
AMP-Activated Protein Kinase Signaling Results in Cytoplasmic Sequestration of p27
Short, J. D., Houston, K. D., Dere, R., Cai, S.-L., Kim, J., Johnson, C. L., Broaddus, R. R., Shen, J., Miyamoto, S., Tamanoi, F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5756 · Cited by 59
Yeh, Y., Cho, Y.-Y., Hsieh, S., & Chiang, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-19553-1 · Cited by 61
Yano, N., Zhang, L., Wei, D., Dubielecka, P. M., Wei, L., Zhuang, S., Zhu, P., Qin, G., Liu, P. Y., Chin, Y. E., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00219.2019 · Cited by 58
Lee, S., Zhang, C., & Liu, X. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.606798 · Cited by 62
AMPK as a therapeutic target in renal cell carcinoma
Woodard, J., Joshi, S. S., Viollet, B., Hay, N., & Platanias, L. C. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.11.13629 · Cited by 62
Self-citationA Raman Spectroscopic Study of Cell Response to Clinical Doses of Ionizing Radiation
Harder, S. J., Matthews, Q., Isabelle, M., Brolo, A. G., Lum, J. J., & Jirasek, A. I. (2015) · Applied Spectroscopy · doi:10.1366/14-07561 · Cited by 63
Jin, S., & Lee, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202933 · Cited by 60
Autophagy and apoptosis mediated nano-copper-induced testicular damage
Chen, H., Wang, Y., Luo, J., Kang, M., Hou, J. L., Tang, R., Zhao, L., Shi, F., Ye, G., He, X., et al. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.113039 · Cited by 60
Metadata
- Authors
- Hahn-Windgassen, A., Nogueira, V., Chen, C.-C., Skeen, J. E., Sonenberg, N., & Hay, N.
- Affiliations
- University of Illinois Chicago (US)
- McGill University (CA)
- Corresponding author
- Hay, Nissim
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 280
- Issue
- 37
- Pages
- 32081-32089
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2170704593
- Cited by
- 539
- References
- 50
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 9 · 2023: 17 · 2022: 24 · 2021: 33 · 2020: 26 · 2019: 27 · 2018: 21 · 2017: 27 · 2016: 26 · 2015: 38 · 2014: 25 · 2013: 42 · 2012: 35
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5504 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- Funders
- National Institute on Aging (R01AG016927, AG016927)
- National Cancer Institute (CA090764, R01CA090764)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007739)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- Akt, mTOR, AMPK, TSC2, AMP/ATP ratio, TSC2 phosphorylation, energy sensing
- MeSH terms
- Tuberous Sclerosis Complex 2 Protein, Adenine, Adenosine Triphosphate, Adenylate Kinase, Animals, Cells, Cultured, Dose-Response Relationship, Drug, Enzyme Activation, Gene Expression Regulation, Humans, Models, Biological, Phosphorylation, Plasmids, Protein Kinases, Proto-Oncogene Proteins, Repressor Proteins, Retroviridae, RNA, Messenger, Time Factors, Transfection, Protein Biosynthesis, Immunoblotting, Gene Expression Regulation, Enzymologic, Protein Serine-Threonine Kinases, Tumor Suppressor Proteins, Immunoprecipitation, Proto-Oncogene Proteins c-akt, Mice, Rats, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.